Patents Assigned to BIOVIE, Inc.
  • Treatment of ascites
    Patent number: 9655945
    Abstract: A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: May 23, 2017
    Assignee: BIOVIE, Inc.
    Inventors: Paolo Angeli, Penelope Markham, Jonathan Adams